FDA Oncology: FDA Oncology's Dan Suzman discusses approaches to oncology trials and regulatory issues

FDA Oncology: FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues

FDA Oncology recently shared a post on X:

“FDA Oncology’s Dan Suzman discusses approaches to oncology trials and regulatory issues in this episode of The Uromigos podcast.”

Source: FDA Oncology/X

cancer Dan Suzman FDA Oncology FDA Oncology's OncoDaily Oncology The Uromigos podcast